Ruirui Jing

593 total citations
19 papers, 345 citations indexed

About

Ruirui Jing is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ruirui Jing has authored 19 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ruirui Jing's work include CAR-T cell therapy research (7 papers), Nanowire Synthesis and Applications (3 papers) and RNA modifications and cancer (2 papers). Ruirui Jing is often cited by papers focused on CAR-T cell therapy research (7 papers), Nanowire Synthesis and Applications (3 papers) and RNA modifications and cancer (2 papers). Ruirui Jing collaborates with scholars based in China, United States and New Zealand. Ruirui Jing's co-authors include Jie Sun, Jing-Hua Yang, Xinyi Xu, Hua Li, Chenqi Xu, Enfu Hui, Kazem M. Azadzoi, Xing He, Min Huang and Xiaoshan Shi and has published in prestigious journals such as Cell, International Journal of Molecular Sciences and Neuroscience.

In The Last Decade

Ruirui Jing

19 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruirui Jing China 11 198 138 88 57 47 19 345
Cristina Corbetta Italy 6 150 0.8× 118 0.9× 128 1.5× 53 0.9× 25 0.5× 9 351
Ekaterina Moroz United States 6 129 0.7× 162 1.2× 58 0.7× 55 1.0× 40 0.9× 9 327
Amanda Finck United States 5 204 1.0× 182 1.3× 199 2.3× 134 2.4× 42 0.9× 8 412
Zuzanna Urban‐Wójciuk Poland 8 143 0.7× 159 1.2× 222 2.5× 36 0.6× 27 0.6× 13 427
Shutan Jiang China 6 292 1.5× 208 1.5× 225 2.6× 59 1.0× 41 0.9× 7 507
Livingstone Fultang United Kingdom 7 216 1.1× 153 1.1× 219 2.5× 54 0.9× 58 1.2× 8 458
Lemei Jia China 7 199 1.0× 130 0.9× 126 1.4× 61 1.1× 37 0.8× 12 323
Silvia Panetti United Kingdom 5 210 1.1× 131 0.9× 252 2.9× 41 0.7× 54 1.1× 6 425
Xiaoli Tian China 11 199 1.0× 107 0.8× 117 1.3× 63 1.1× 35 0.7× 15 316
Mayuresh Mane United States 5 104 0.5× 75 0.5× 56 0.6× 32 0.6× 26 0.6× 10 203

Countries citing papers authored by Ruirui Jing

Since Specialization
Citations

This map shows the geographic impact of Ruirui Jing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruirui Jing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruirui Jing more than expected).

Fields of papers citing papers by Ruirui Jing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruirui Jing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruirui Jing. The network helps show where Ruirui Jing may publish in the future.

Co-authorship network of co-authors of Ruirui Jing

This figure shows the co-authorship network connecting the top 25 collaborators of Ruirui Jing. A scholar is included among the top collaborators of Ruirui Jing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruirui Jing. Ruirui Jing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Yang, Tingting, Rongrong Chen, Mingming Zhang, et al.. (2024). Relapsed/Refractory Peripheral T-Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis With UNC13D and CD27 Germline Mutations. Cell Transplantation. 33. 4231279743–4231279743. 1 indexed citations
3.
Fu, Shan, Qiqi Zhang, Ruirui Jing, et al.. (2023). HBV reactivation in patients with chronic or resolved HBV infection following BCMA-targeted CAR-T cell therapy. Bone Marrow Transplantation. 58(6). 701–709. 10 indexed citations
5.
Kong, Delin, Tingting Yang, Jia Geng, et al.. (2022). Secondary donor-derived CD19 CAR-T therapy is safe and efficacious in acute lymphoblastic leukemia with extramedullary relapse after first autologous CAR-T therapy. Journal of Zhejiang University SCIENCE B. 23(10). 876–880. 1 indexed citations
6.
Chen, Xiaxia, et al.. (2021). Effects of music therapy on cancer-related fatigue, anxiety, and depression in patients with digestive tumors. Medicine. 100(22). e25681–e25681. 12 indexed citations
7.
Jing, Ruirui, Peng Jiao, Jiangqing Chen, et al.. (2021). Cas9‐Cleavage Sequences in Size‐Reduced Plasmids Enhance Nonviral Genome Targeting of CARs in Primary Human T Cells. Small Methods. 5(7). e2100071–e2100071. 22 indexed citations
8.
Meng, Xianhui, Xiaoyan Wu, Ruirui Jing, et al.. (2020). Exploiting Ca2+ signaling in T cells to advance cancer immunotherapy. Seminars in Immunology. 49. 101434–101434. 8 indexed citations
9.
Wu, Wei, Qiuping Zhou, Takeya Masubuchi, et al.. (2020). Multiple Signaling Roles of CD3ε and Its Application in CAR-T Cell Therapy. Cell. 182(4). 855–871.e23. 137 indexed citations
10.
Meng, Xianhui, Ruirui Jing, Liling Qian, Chun Zhou, & Jie Sun. (2020). Engineering Cytoplasmic Signaling of CD28ζ CARs for Improved Therapeutic Functions. Frontiers in Immunology. 11. 1046–1046. 22 indexed citations
11.
Wang, Haoran, et al.. (2020). A design of Automatic UAV Dock Platform System. Journal of Physics Conference Series. 1650(2). 22068–22068. 8 indexed citations
12.
Song, Yang, Qing Wang, Desheng Wang, et al.. (2018). Label-Free Quantitative Proteomics Unravels Carboxypeptidases as the Novel Biomarker in Pancreatic Ductal Adenocarcinoma. Translational Oncology. 11(3). 691–699. 20 indexed citations
13.
Li, Feng, Cuiling Li, Ruirui Jing, et al.. (2017). Label-free quantitative proteomics unravels the importance of RNA processing in glioma malignancy. Neuroscience. 351. 84–95. 16 indexed citations
15.
Li, Cuiling, Han-Pil Choi, Xiaoyue Wang, et al.. (2017). Post-Translational Modification of Human Histone by Wide Tolerance of Acetylation. Cells. 6(4). 34–34. 13 indexed citations
16.
Zhao, Zuohui, Kazem M. Azadzoi, Han-Pil Choi, et al.. (2017). LC-MS/MS Analysis Unravels Deep Oxidation of Manganese Superoxide Dismutase in Kidney Cancer. International Journal of Molecular Sciences. 18(2). 319–319. 14 indexed citations
17.
Jing, Ruirui, Junqiang Li, Lin Li, et al.. (2016). H2A/K pseudogene mutation may promote cell proliferation. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 787. 32–42. 2 indexed citations
18.
Wang, Xiaoyue, Xin Lü, Ruirui Jing, et al.. (2016). Unraveling molecular effects of ADAR1 overexpression in HEK293T cells by label-free quantitative proteomics. Cell Cycle. 15(12). 1591–1601. 6 indexed citations
19.
Dai, Peng, Qin Wang, Weihua Wang, et al.. (2016). Unraveling Molecular Differences of Gastric Cancer by Label-Free Quantitative Proteomics Analysis. International Journal of Molecular Sciences. 17(1). 69–69. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026